NovaBridge Biosciences
NBP
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 20-F |
4/7/2026 |
Q4 |
2025 |
12/31/2025
|
SEC |
view |
|
| 6-K |
12/18/2025 |
Q3 |
2025 |
9/30/2025
|
SEC |
view |
|
| 6-K |
10/6/2025 |
Q2 |
2025 |
6/30/2025
|
SEC |
view |
|
| WIREPR |
8/20/2025 |
Q2 |
2025 |
6/30/2025
|
WIRE |
view |
data |
| WIREPR |
5/15/2025 |
Q1 |
2025 |
3/31/2025
|
WIRE |
view |
data |
| WIREPR |
4/3/2025 |
Q4 |
2024 |
12/31/2024
|
WIRE |
view |
data |
| 20-F |
4/3/2025 |
Q4 |
2024 |
12/31/2024
|
SEC |
view |
|
| WIREPR |
11/14/2024 |
Q3 |
2024 |
9/30/2024
|
WIRE |
view |
data |
| WIREPR |
8/28/2024 |
Q2 |
2024 |
6/30/2024
|
WIRE |
view |
data |
| 20-F |
4/30/2024 |
Q4 |
2023 |
12/31/2023
|
SEC |
view |
|
| WIREPR |
3/14/2024 |
Q4 |
2023 |
12/31/2023
|
WIRE |
view |
data |
| WIREPR |
8/17/2023 |
Q2 |
2023 |
6/30/2023
|
WIRE |
view |
data |
| 20-F |
5/1/2023 |
Q4 |
2022 |
12/31/2022
|
SEC |
view |
|
| WIREPR |
3/31/2023 |
Q4 |
2022 |
12/31/2022
|
WIRE |
view |
data |
| 6-K |
11/10/2022 |
Q2 |
2022 |
6/30/2022
|
SEC |
view |
|
| 20-F |
4/29/2022 |
Q4 |
2021 |
12/31/2021
|
SEC |
view |
|
| WIREPR |
3/29/2022 |
Q4 |
2021 |
12/31/2021
|
WIRE |
view |
data |
| WIREPR |
8/31/2021 |
Q2 |
2021 |
6/30/2021
|
WIRE |
view |
data |
| 20-F |
4/28/2021 |
Q4 |
2020 |
12/31/2020
|
SEC |
view |
|
| WIREPR |
3/29/2021 |
Q4 |
2020 |
12/31/2020
|
WIRE |
view |
data |
| 6-K |
2/5/2021 |
Q3 |
2020 |
9/30/2020
|
SEC |
view |
|
| F-1 |
12/1/2020 |
Q4 |
2019 |
12/31/2019
|
SEC |
view |
|
| WIREPR |
8/31/2020 |
Q4 |
2019 |
12/31/2019
|
WIRE |
view |
data |
| 20-F |
4/29/2020 |
Q4 |
2019 |
12/31/2019
|
SEC |
view |
|